PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fiona Stanley Hospital, Murdoch, WA, Australia.\', \'PathWest Laboratory Medicine, Murdoch, WA, Australia.\', \'Westmead Hospital, Sydney, NSW, Australia.\', \'Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.\', \'The Royal Melbourne Hospital, Melbourne, VIC, Australia.\', \'Royal Prince Alfred Hospital, Sydney, NSW, Australia.\', \'Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.\', \'St Vincent\'s Hospital, Darlinghurst, NSW, Australia.\', \'Royal Brisbane and Woman\'s Hospital, Herston, QLD, Australia.\', \'Alfred Health, Melbourne, VIC, Australia.\', \'Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.\', \'Liverpool Hospital, Liverpool, NSW, Australia.\', \'Royal North Shore Hospital, St Leonards, NSW, Australia; and.\', \'Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1182/bloodadvances.2020002431
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 32886750
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all